| Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach—the ALBI grade PJ Johnson, S Berhane, C Kagebayashi, S Satomura, M Teng, ... Journal of Clinical Oncology 33 (6), 550-558, 2015 | 2528 | 2015 |
| Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis YMD Lo, MSC Tein, TK Lau, CJ Haines, TN Leung, PMK Poon, ... The American Journal of Human Genetics 62 (4), 768-775, 1998 | 2486 | 1998 |
| Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study JW Park, M Chen, M Colombo, LR Roberts, M Schwartz, PJ Chen, ... Liver International 35 (9), 2155-2166, 2015 | 1300 | 2015 |
| Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma YMD Lo, LYS Chan, KW Lo, SF Leung, J Zhang, ATC Chan, JCK Lee, ... Cancer research 59 (6), 1188-1191, 1999 | 991 | 1999 |
| Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors W Yeo, PKS Chan, S Zhong, WM Ho, JL Steinberg, JS Tam, P Hui, ... Journal of medical virology 62 (3), 299-307, 2000 | 896 | 2000 |
| Brivanib versus sorafenib as first-line therapy in patients with unresectable, advanced hepatocellular carcinoma: results from the randomized phase III BRISK-FL study PJ Johnson, S Qin, JW Park, RTP Poon, JL Raoul, PA Philip, CH Hsu, ... Journal of clinical oncology 31 (28), 3517-3524, 2013 | 871 | 2013 |
| A randomized phase III study of doxorubicin versus cisplatin/interferon α-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma W Yeo, TS Mok, B Zee, TWT Leung, PBS Lai, WY Lau, J Koh, FKF Mo, ... Journal of the National Cancer Institute 97 (20), 1532-1538, 2005 | 815 | 2005 |
| Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the … TWT Leung, AMY Tang, B Zee, WY Lau, PBS Lai, KL Leung, JTF Lau, ... Cancer 94 (6), 1760-1769, 2002 | 752 | 2002 |
| Overall survival after concurrent cisplatin–radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma ATC Chan, SF Leung, RKC Ngan, PML Teo, WH Lau, WH Kwan, EP Hui, ... Journal of the National Cancer Institute 97 (7), 536-539, 2005 | 739 | 2005 |
| Detection of Aberrant p16 Methylation in the Plasma and Serum of Liver Cancer Patients IHN Wong, YM Dennis Lo, J Zhang, CT Liew, MHL Ng, N Wong, PBS Lai, ... Cancer research 59 (1), 71-73, 1999 | 715 | 1999 |
| Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy W Yeo, PJ Johnson Hepatology 43 (2), 209-220, 2006 | 666 | 2006 |
| Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma … M Kudo, K Ueshima, M Ikeda, T Torimura, N Tanabe, H Aikata, N Izumi, ... Gut 69 (8), 1492-1501, 2020 | 651 | 2020 |
| Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III … ATC Chan, PML Teo, RK Ngan, TW Leung, WH Lau, B Zee, SF Leung, ... Journal of clinical oncology 20 (8), 2038-2044, 2002 | 644 | 2002 |
| Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trial GK Abou-Alfa, P Johnson, JJ Knox, M Capanu, I Davidenko, J Lacava, ... Jama 304 (19), 2154-2160, 2010 | 579 | 2010 |
| Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma YM Dennis Lo, LYS Chan, ATC Chan, SF Leung, KW Lo, J Zhang, ... Cancer research 59 (21), 5452-5455, 1999 | 522 | 1999 |
| The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma PJ Johnson Clinics in liver disease 5 (1), 145-159, 2001 | 510 | 2001 |
| Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind … T Meyer, R Fox, YT Ma, PJ Ross, MW James, R Sturgess, C Stubbs, ... The lancet Gastroenterology & hepatology 2 (8), 565-575, 2017 | 501 | 2017 |
| Azathioprine for long-term maintenance of remission in autoimmune hepatitis PJ Johnson, IG McFarlane, R Williams New England Journal of Medicine 333 (15), 958-963, 1995 | 494 | 1995 |
| Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma ATC Chan, YMD Lo, B Zee, LYS Chan, BBY Ma, SF Leung, F Mo, M Lai, ... Journal of the National Cancer Institute 94 (21), 1614-1619, 2002 | 490 | 2002 |
| The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality TH Karlsen, N Sheron, S Zelber-Sagi, P Carrieri, G Dusheiko, E Bugianesi, ... The Lancet 399 (10319), 61-116, 2022 | 476 | 2022 |
